ACTONEL WITH CALCIUM (COPACKAGED) Drug Patent Profile
✉ Email this page to a colleague
When do Actonel With Calcium (copackaged) patents expire, and what generic alternatives are available?
Actonel With Calcium (copackaged) is a drug marketed by Warner Chilcott and is included in one NDA.
The generic ingredient in ACTONEL WITH CALCIUM (COPACKAGED) is calcium carbonate; risedronate sodium. There are two hundred and eighty-two drug master file entries for this compound. Additional details are available on the calcium carbonate; risedronate sodium profile page.
Summary for ACTONEL WITH CALCIUM (COPACKAGED)
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ACTONEL WITH CALCIUM (COPACKAGED) at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ACTONEL WITH CALCIUM (COPACKAGED)
US Patents and Regulatory Information for ACTONEL WITH CALCIUM (COPACKAGED)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Warner Chilcott | ACTONEL WITH CALCIUM (COPACKAGED) | calcium carbonate; risedronate sodium | TABLET;ORAL | 021823-001 | Aug 12, 2005 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ACTONEL WITH CALCIUM (COPACKAGED)
International Patents for ACTONEL WITH CALCIUM (COPACKAGED)
See the table below for patents covering ACTONEL WITH CALCIUM (COPACKAGED) around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 122006000009 | ⤷ Try a Trial | |
China | 1274279 | ⤷ Try a Trial | |
Estonia | 05603 | Alendronaadi kasutamine ravimi valmistamiseks osteoporoosi raviks | ⤷ Try a Trial |
Canada | 2294595 | INHIBITION DE RESORPTION OSSEUSE (INHIBITING BONE RESORPTION) | ⤷ Try a Trial |
Russian Federation | 2193880 | FILM-COVERED TABLET OF IMPROVED SAFETY FOR UPPER DEPARTMENTS OF GASTROINTESTINAL TRACT | ⤷ Try a Trial |
Iceland | 7231 | ⤷ Try a Trial | |
Turkey | 200000111 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ACTONEL WITH CALCIUM (COPACKAGED)
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1175904 | C01175904/01 | Switzerland | ⤷ Try a Trial | FORMER OWNER: SCHERING CORPORATION, US |
0933372 | PA2008006 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712 |
2957286 | 132019000000021 | Italy | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM E QUALSIASI SUO SALE O DERIVATO(VELTASSA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1179, 20170721 |
0998292 | PA2006002 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: NATRIUM ALENDRONICUM/COLECACIFEROLUM; REGISTRATION NO/DATE: EU/1/05/310/001, EU/1/05/310/002, EU/1/05/310/003, EU/1/05/310/004, EU/1/05/310/005 20050824 |
0186405 | 2000C/028 | Belgium | ⤷ Try a Trial | PRODUCT NAME: NATRIUMRISEDRONAAT; NAT. REGISTRATION NO/DATE: 354 IS 498 F3 20000508; FIRST REGISTRATION: SE 15290 19991007 |
0933372 | 13/2008 | Austria | ⤷ Try a Trial | PRODUCT NAME: FOSAMPRENAVIR ALS FOSAMPRENAVIR-CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001 - EU/1/04/282/002 (MITTEILUNG VOM 14.07.2004) 20040713 |
0933372 | PA2008006,C0933372 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |